2025-01-24 02:26:23 pm | Source: Motilal Oswal Financial Services Ltd
Company Update : Mahindra Finance By Motilal Oswal Financial Services Ltd
Business Assets rose ~18% YoY | Stage 2+Stage 3 remains stable QoQ
Key takeaways from Dec’24 business update:
* 3QFY25 disbursements at INR164.5b, grew 7% YoY. 9MFY25 disbursements stood at ~INR423.5b and grew ~4% YoY.
* Gross business assets as of Dec’24 stood at ~INR1.15t, up 18% YoY/2% QoQ.
* 3QFY25 CE stood at 95% (PY: 95% and PQ: 96%).
* MMFS reported that its Stage 3 is estimated at 3.9% (PQ: 3.8%) and Stage 2 is estimated at 6.3% (PQ: 6.4%).
* As of Dec’24, MMFS maintained a comfortable liquidity position with a liquidity chest of ~INR91b
For More Research Reports : Click Here
For More Motilal Oswal Securities Ltd Disclaimer
http://www.motilaloswal.com/MOSLdisclaimer/disclaimer.html
SEBI Registration number is INH000000412
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
ICICI Bank's Q4 profit rises 18 pc to Rs 12,630 cror...
Robust India-Saudi Arabia Strategic Partnership set ...
HDFC Bank posts nearly 7 pc rise in net profit at Rs...
Foreign investors infuse Rs 8,500 crore into Indian ...
MTNL defaults on over Rs 8,300 crore loan repayments...
Honour to speak with PM Narendra Modi, look forward ...
Yes Bank?s Q4 profit jumps 64 pc to Rs 738 crore, ne...
Indian stock markets rally over 4.5 pc in holiday-sh...
Active companies in India up by over 1.62 lakh in FY25
India?s pharma exports surpass $30 billion in FY25, ...
